semaglutide and lamictal | GLP-1 RA | Clinical Development LAMOTRIGINE LAMICTAL, requires slow titration

Elevating Physical Energy Levels with GLP-Activation Low energy often accompanies restrictive diets, making exercise and daily activities harder to sustain

Miner Endocrinol

Compounded medication considerations Compounded GLP-1 medications are not FDA-approved products

Research Shows GLP-1 Receptor Agonist Drugs are Effective but Come With Complex Concerns

Peptide-1 Agonist Relieves IBS Pain but Raises Side Effects The following is a summary of Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a systematic review and meta-analysis, published in the March 2025 issue of Frontiers in Endocrinology by Mostafa and Alrasheed